Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2013; 19(21): 3207-3216
Published online Jun 7, 2013. doi: 10.3748/wjg.v19.i21.3207
Table 1 Hepatocellular carcinoma mortality by patient’s characteristics n (%)
YesNoTotalP value
GenderMen120 (67.8)57 (32.2)1770.24
Women52 (74.3)18 (25.7)70
Age (yr) ≤ 6539 (61.9)24 (38.1)630.17
> 65133 (72.3)51 (27.7)184
Calendar period2000-2005116 (92.1)10 (7.9)126< 0.01
2006-201056 (46.3)65 (53.7)121
EtiologyViral infection108 (69.7)47 (30.3)155< 0.01
Alcohol38 (80.9)9 (19.1)47
Other25 (56.8)19 (43.2)44
BCLC stageA59 (56.7)45 (43.3)104< 0.01
B79 (74.5)27 (25.5)106
C-D34 (91.9)3 (8.1)37
TreatmentNo60 (93.8)4 (6.3)640.04
Yes112 (61.2)71 (38.8)183
SurveillanceNo134 (72.0)52 (28.0)1860.20
Yes38 (62.3)23 (37.7)61
Alpha-fetoproteinNormal104 (59.8)70 (40.2)174< 0.01
Elevated (> 15)43 (91.5)4 (8.5)47
BilirubinNormal48 (57.8)35 (42.2)83< 0.01
Elevated (> 2.1)98 (77.8)28 (22.2)126